Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Fish and Richardson
Citi
Federal Trade Commission
AstraZeneca
Daiichi Sankyo
Merck
McKinsey

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203887

« Back to Dashboard

NDA 203887 describes DAPSONE, which is a drug marketed by Taro, Actavis Llc, Alvogen, Jacobus, Nostrum Labs Inc, Novitium Pharma, and Virtus Pharms, and is included in eight NDAs. It is available from fourteen suppliers. Additional details are available on the DAPSONE profile page.

The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 203887
Tradename:DAPSONE
Applicant:Nostrum Labs Inc
Ingredient:dapsone
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 203887
Ingredient-typeSulfones
Medical Subject Heading (MeSH) Categories for 203887
Suppliers and Packaging for NDA: 203887
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DAPSONE dapsone TABLET;ORAL 203887 ANDA Nostrum Laboratories, Inc. 29033-036 N 29033-036-30
DAPSONE dapsone TABLET;ORAL 203887 ANDA Nostrum Laboratories, Inc. 29033-037 N 29033-037-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:May 6, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:May 6, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Accenture
Medtronic
Citi
QuintilesIMS
McKinsey
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.